| Literature DB >> 28865366 |
Huihua Chen1, Haiyan Song2, Xiao Liu1, Jing Tian1, Wenzhu Tang1, Tongtong Cao2, Pei Zhao2, Chen Zhang1, Wei Guo1, Ming Xu3, Rong Lu4.
Abstract
Buyanghuanwu Decoction (BHD), a traditional Chinese medicine recipe, is a representative prescription for the treatment of qi-deficiency and blood-stasis syndrome. In this study, the effect of BHD on pressure overload induced cardiac remodeling was investigated and possible mechanism underlying was explored. Rats were randomly divided into four groups: sham, transverse aorta constriction (TAC) with saline, TAC with telmisartan (TAC+Tel), and TAC with BHD (TAC+BHD) for 16 weeks (n=6∼8 in each group). Cardiac morphological and functional changes were evaluated by echocardiography and histological methods, the molecular alterations were detected by western blotting. Our results revealed that pressure overload prominently induced cardiac dysfunction, dilated and atrophied left ventricle, decreased cardiomyocyte cross sectional area, and fibrosis. However, BHD, similar to Tel, greatly reversed cardiac dysfunction, left ventricular dilation, and fibrosis, together with increased left ventricular wall thickness and size of cardiomyocyte. Furthermore, activated classical pro-fibrotic signaling of Tgf-β/Smads and MAPKs after TAC was dramatically suppressed by BHD or Tel treatment. Taken together, it was demonstrated in this study that BHD exerted a cardioprotective effect against pressure overload induced cardiac remodeling via inactivation of Tgf-β/Smads and MAPKs signaling triggered fibrosis.Entities:
Keywords: Buyanghuanwu Decoction; Cardiac remodeling; Fibrosis; Mitogen-activated protein kinases; Smads; Transformation growth factor-β
Mesh:
Substances:
Year: 2017 PMID: 28865366 DOI: 10.1016/j.biopha.2017.08.102
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529